Skip to content

What is the drug Eliquis used for?: A Comprehensive Guide

4 min read

Eliquis (apixaban) is the most prescribed oral blood thinner for preventing and treating dangerous blood clots. This medication plays a critical role in managing conditions such as atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). So, what is the drug Eliquis used for? It is a direct-acting oral anticoagulant that works by inhibiting a key enzyme in the body's clotting process.

Quick Summary

Eliquis (apixaban) is a direct oral anticoagulant prescribed to prevent strokes in patients with atrial fibrillation and to treat or prevent deep vein thrombosis and pulmonary embolism by inhibiting a clotting factor.

Key Points

  • Blood Clot Prevention: Eliquis is used to prevent strokes in patients with non-valvular atrial fibrillation (AFib) by inhibiting blood clot formation in the heart.

  • Blood Clot Treatment: The medication effectively treats existing deep vein thrombosis (DVT) and pulmonary embolism (PE), and is also used to prevent their recurrence.

  • Factor Xa Inhibitor: Eliquis is a direct oral anticoagulant (DOAC) that works by blocking Factor Xa, a crucial enzyme in the blood clotting process.

  • No Routine Monitoring: Unlike warfarin, Eliquis does not require patients to undergo frequent blood tests (INR monitoring).

  • Risk of Bleeding: The most common side effect is bleeding, which can range from minor bruising to serious internal bleeding. It is vital to report any unusual bleeding to a doctor immediately.

  • Precautions: Eliquis should not be stopped abruptly due to an increased risk of thrombotic events. Patients should inform healthcare providers of all other medications and before any medical procedures.

In This Article

Understanding Eliquis and Its Mechanism of Action

Eliquis, known by its generic name apixaban, is a direct-acting oral anticoagulant (DOAC). It is part of a class of drugs called Factor Xa inhibitors, which target and block a specific enzyme, Factor Xa, that is vital for blood clot formation. By inhibiting this enzyme, Eliquis disrupts the blood clotting cascade, preventing clots from forming or growing larger without interfering with other steps of the process. This targeted approach provides a more predictable and consistent anticoagulant effect compared to older-generation blood thinners like warfarin. Its use does not typically require frequent blood tests, making it a more convenient option for many patients.

Primary Uses of Eliquis

Eliquis is an FDA-approved medication used for several specific conditions related to blood clot prevention and treatment.

Atrial Fibrillation (AFib)

In patients with non-valvular atrial fibrillation (an irregular and often rapid heart rate not caused by a heart valve problem), blood can pool in the heart and form clots. If a clot breaks loose and travels to the brain, it can cause a stroke. Eliquis is prescribed to reduce this risk of stroke and systemic embolism in individuals with AFib. Clinical studies have shown Eliquis to be more effective than warfarin at preventing strokes and causing significantly less major bleeding.

Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)

Eliquis is used to both treat existing blood clots and reduce the risk of their recurrence.

  • Treatment: For patients with an acute DVT (a blood clot in the deep veins, usually in the legs) or PE (a blood clot that has traveled to the lungs), Eliquis is used to treat the existing clot and prevent complications.
  • Recurrence Prevention: After initial therapy, a lower dose of Eliquis can be prescribed to reduce the risk of a new DVT or PE forming.

Post-Surgery Blood Clot Prevention

Following certain surgical procedures, particularly hip or knee replacement, patients are at a higher risk of developing DVTs. Eliquis is used as a preventative measure (prophylaxis) in these patients to minimize this risk. The duration of treatment is typically specified by the surgeon and is based on the type of surgery.

Comparison of Eliquis with Other Anticoagulants

Eliquis is one of several anticoagulants available. Here is a comparison with two common alternatives:

Feature Eliquis (Apixaban) Warfarin (Coumadin) Xarelto (Rivaroxaban)
Drug Class Direct Oral Anticoagulant (DOAC); Factor Xa Inhibitor Vitamin K Antagonist Direct Oral Anticoagulant (DOAC); Factor Xa Inhibitor
Mechanism Blocks Factor Xa, an enzyme critical for clotting Interferes with Vitamin K production of clotting factors Blocks Factor Xa
Dosing Twice daily (most common) Once daily, dose adjusted based on INR Once or twice daily, depending on indication
Monitoring No routine blood monitoring required Requires frequent PT/INR blood tests No routine blood monitoring required
Dietary Impact No dietary restrictions Requires consistent intake of Vitamin K-rich foods No dietary restrictions
Bleeding Risk Lower risk of major bleeding vs. warfarin; Possibly lower risk than Xarelto Higher risk of major bleeding vs. Eliquis Similar or possibly higher risk of major bleeding vs. Eliquis

Potential Side Effects and Safety Considerations

As a blood thinner, the most significant risk associated with Eliquis is bleeding. Patients should be aware of both mild and serious side effects.

Common Side Effects

  • Bleeding and bruising more easily than usual.
  • Nausea.
  • Minor nosebleeds.
  • Anemia.

Serious Side Effects and Risks

  • Severe Bleeding: This can manifest as bloody or tar-like stools, red or dark brown urine, coughing or vomiting blood, or severe, unstoppable bleeding. Seek immediate medical attention if these symptoms occur.
  • Spinal or Epidural Hematoma: There is an increased risk of blood clots forming around the spine following a spinal puncture or epidural procedure, which can lead to paralysis.
  • Allergic Reactions: Though rare, severe allergic reactions can occur, requiring immediate medical care.

Important Precautions and Contraindications

Eliquis is not suitable for everyone. It is contraindicated in patients with active pathological bleeding or severe hypersensitivity to the drug. It is also not recommended for those with prosthetic heart valves or severe liver disease. Your doctor will also need to consider your kidney function before prescribing Eliquis.

Drug and Food Interactions

While Eliquis has fewer interactions than warfarin, certain medications and supplements can increase the risk of bleeding. These include:

  • Other anticoagulants and antiplatelet agents (e.g., aspirin, NSAIDs).
  • Certain antifungals and antivirals.
  • Herbal supplements like St. John's Wort.
  • Grapefruit, grapefruit juice, and other related citrus fruits should be avoided as they can increase Eliquis levels in the blood.

Important Considerations Before and During Treatment

Patients must follow their prescription exactly and never stop taking Eliquis without consulting their healthcare provider. Abrupt discontinuation can significantly increase the risk of developing a dangerous blood clot or stroke. If a surgical or dental procedure is planned, inform your healthcare team, as they may need to temporarily adjust your medication schedule. During treatment, if a fall or significant injury occurs, contact your doctor immediately, especially if you hit your head.

Conclusion

Eliquis (apixaban) is a highly effective anticoagulant used to prevent and treat serious blood clots related to conditions like atrial fibrillation, DVT, and PE. Its mechanism as a Factor Xa inhibitor offers a more targeted and convenient treatment option compared to traditional blood thinners like warfarin, as it requires no routine blood monitoring and has fewer dietary restrictions. However, it is a high-alert medication that increases the risk of bleeding and requires careful management and patient education. Before starting or stopping any anticoagulant therapy, patients must have a thorough discussion with their healthcare provider to ensure it is the safest and most appropriate choice for their specific medical needs. For more information, visit a reliable medical resource such as WebMD.

Frequently Asked Questions

Besides preventing strokes in people with atrial fibrillation, Eliquis is also used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). It can also be prescribed to prevent blood clots after hip or knee replacement surgery.

Eliquis is a newer-generation blood thinner that works by directly inhibiting Factor Xa, while warfarin is a Vitamin K antagonist. Eliquis works faster, does not require routine blood monitoring (INR), and has fewer dietary restrictions than warfarin.

Unlike warfarin, Eliquis does not require major dietary changes related to Vitamin K intake. However, you should avoid grapefruit and grapefruit juice, as they can interact with the medication and increase blood levels, raising the risk of bleeding.

If you miss a dose of Eliquis, you should take it as soon as you remember on the same day. Do not take two doses at the same time to make up for a missed dose. If you miss more than one dose, contact your doctor or pharmacist.

Do not stop taking Eliquis without talking to your healthcare provider, as abrupt discontinuation can increase your risk of a stroke or blood clot. Your doctor will provide specific instructions for stopping and restarting the medication around a procedure.

The most common side effects include increased bruising, minor bleeding (e.g., nosebleeds), and nausea. More serious bleeding is also a risk and requires immediate medical attention.

Yes, an antidote called andexanet alfa was approved in 2018 for reversing the anticoagulant effects of Eliquis and other Factor Xa inhibitors in the event of life-threatening or uncontrollable bleeding.

There is a risk of developing a blood clot in the spinal or epidural area, which can cause paralysis, especially in patients undergoing spinal anesthesia or puncture. Patients should be monitored closely for any neurological symptoms.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.